Zenodo and Figshare Publications Currently Not Listed in Google Scholar!
Zenodo and Figshare Publications Currently Not Listed in Google Scholar!
Dear Scientists and Interested Parties,
We want to inform you about a significant development in the scientific publishing landscape. Our team has recently discovered that works published on the renowned open-access platforms Zenodo and Figshare are currently not appearing in Google Scholar search results.
This situation affects not only our research on Oshtoran Syndrome but also publications from numerous other institutions, including the esteemed Robert Koch Institute. The scope of this issue is considerable and could significantly impact the visibility and dissemination of important scientific findings.
Key points:
1. Cause: The exact reasons for this indexing problem are still unclear. We are investigating the situation and are in contact with the affected platforms.
2. Impact: This development could limit the discoverability and accessibility of current research findings, especially for scientists and clinicians who rely heavily on Google Scholar.
3. Our Response: To ensure the visibility of our research, we have decided to additionally publish our work on ResearchGate. This is a temporary measure until the issue is resolved.
4. Call for Vigilance: We encourage all researchers using Zenodo and Figshare to check the indexing of their work and consider alternative dissemination methods if necessary.
5. Broader Implications: This situation underscores the need for diverse and robust systems for disseminating scientific findings to avoid dependency on single platforms.
We remain vigilant about this issue and will keep you informed of any significant developments. Despite this challenge, we remain committed to our dedication to open access and the wide availability of scientific knowledge.
Please feel free to contact us with any questions or for further information. Together, we can ensure that important research, such as that on Oshtoran Syndrome, remains easily accessible.
Best scientific regards,
International H63D Syndrome Research Consortium